10 results · 29ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

BOSS

FDA 510(k)
FDA Class 2 ·Dental

Novo Surgical Inc.

FDA UDI
NOVO SURGICAL, INC.·00842331180118·beebee (crown & collar) wire cutting scissors, ...

Portex

FDA UDI
ICU MEDICAL, INC.·10351688403285·

ACTICOAT Surgical Dressing

FDA 510(k)
FDA Unclassified ·Unknown

Branchor Balloon Guide Catheter

FDA 510(k)
FDA Class 2 ·Cardiovascular

COGNIS HE IS-1/DF-1/IS-1

FDA Adverse Event
Malfunction ·CARDIAC PACEMAKERS, INC·Product code NIK·November 11, 2008

ASR ACETABULAR IMPLANT 50

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL·Product code KWA·September 19, 2011

ACCU-CHEK ® SPIRIT COMBO

FDA Adverse Event
Malfunction ·ROCHE HEALTH SOLUTIONS, INC.·Product code LZG·July 30, 2013

BD Intelliport Medication Management System Sensor The system is indicated for use by healthcare professionals in a hospital or medical center setting with patients who are receiving manually administered bolus intravenous injections as part of their care to facilitate documentation of the medications.

FDA Enforcement
Class II ·Terminated·Becton Dickinson & Company·March 16, 2016

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014